• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Diagnosis of Recurrent C Difficile Infections

Opinion
Video

The panelist discusses how recurrent Clostridioides difficile infections involve complex differential diagnosis, including persistent infection, reinfection, and other gastrointestinal conditions. Definitive diagnosis requires molecular and immunological testing of stool samples to detect toxin genes and active toxin production.

Video content above is prompted by the following:

  • What is in your differential diagnosis when considering recurrent C difficile infections?
  • How is a definitive diagnosis made?
Related Videos
4 Experts are featured in this series
5 experts are featured in this series
4 experts are featured in this series.
4 Experts are featured in this series
4 experts are featured in this series.
5 experts are featured in this series
Related Content
Our top ASCO 2025 highlights include new survival gains in key cancer trials, advances in AI-driven clinical decision support, and emerging evidence linking GLP-1 therapies to reduced cancer risk.

ICYMI: Highlights From ASCO 2025

December 22nd 2025
Article

ASCO 2025 highlighted breakthroughs, including improved cancer survival in key trials, new AI guideline tools, and expanding GLP-1 cancer research.

Read More

Managed Care Cast Square thumbnail

Managed Care Cast Presents: New Evidence and Economic Considerations in IPF Care

November 25th 2025
Podcast

Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.

Listen

AJMC original research clinical

HEDIS Glycemic Goal Achieved Using Control-IQ Technology

December 22nd 2025
Article

A greater proportion of patients with type 1 diabetes who used automated insulin delivery systems vs multiple daily injections achieved the Healthcare Effectiveness Data and Information Set (HEDIS) glycemic measure.

Read More

Inside the Discovery That Changed CML Treatment Forever: Jorge Cortes, MD

Inside the Discovery That Changed CML Treatment Forever: Jorge Cortes, MD

November 11th 2025
Podcast

Lead CML researcher discusses the evolution of a groundbreaking treatment and its effect on patient survival.

Listen

3D illustration of ovarian cancer | Image Credit: Lars Neumann - stock.adobe.com

Fuzuloparib Monotherapy Improves PFS in Advanced Ovarian Cancer, but Adding Apatinib Offers No Additional Benefit

December 21st 2025
Article

Fuzuloparib extended progression-free survival, regardless of the addition of apatinib in patients with newly diagnosed advanced ovarian cancer.

Read More

Top 5 inflammation articles | Image Credit: Venngage

Top 5 Inflammation Articles of 2025

December 21st 2025
Article

This year's top inflammation article highlighted the first FDA-approved treatment for patients with bronchiectasis.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.